Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
1.00T
Market cap1.00T
Price-Earnings ratio
52.64
Price-Earnings ratio52.64
Dividend yield
0.56%
Dividend yield0.56%
Average volume
2.83M
Average volume2.83M
High today
$1,067.08
High today$1,067.08
Low today
$1,043.32
Low today$1,043.32
Open price
$1,062.50
Open price$1,062.50
Volume
2.24M
Volume2.24M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

As of today, Eli Lilly(LLY) shares are valued at $1,061.00. The company's market cap stands at 1T, with a P/E ratio of 52.64 and a dividend yield of 56.4%.

On 2026-01-26, Eli Lilly(LLY) stock moved within a range of $1,043.32 to $1,067.08. With shares now at $1,061.00, the stock is trading +1.7% above its intraday low and -0.6% below the session's peak.

Trading volume for Eli Lilly(LLY) stock has reached 2.24M, versus its average volume of 2.83M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

LLY News

The Motley Fool 9h
Eli Lilly or Viking Therapeutics: Which Stock Is More Likely to be a Millionaire-Maker?

Both companies may succeed in this industry. Pharmaceutical giant Eli Lilly (LLY 0.12%) and biotech Viking Therapeutics (VKTX 0.12%) have one major thing in co...

Eli Lilly or Viking Therapeutics: Which Stock Is More Likely to be a Millionaire-Maker?
24/7 Wall St. 10h
NVIDIA Partners With Eli Lilly in $1 Billion AI Drug Discovery Lab Deal

NVIDIA Just Made a Bigger Push Into AI Drug Discovery Quick Read Nvidia formed a $1B partnership with Eli Lilly to develop a co-innovation AI lab for drug disc...

TipRanks 10h
Eli Lilly’s New Marketing Focuses on ‘Weight Stigma’

Eli Lilly’s (LLY) new marketing campaign focuses on weight stigma and healthy body image. Claim 50% Off TipRanks Premium The pharmaceutical company has unveil...

Analyst ratings

80%

of 30 ratings
Buy
80%
Hold
16.7%
Sell
3.3%

More LLY News

The Motley Fool 13h
My Top AI Healthcare Stock to Buy and Hold for 20 Years

This drugmaker continues to strengthen its investment thesis. Artificial intelligence (AI) isn't just a gimmick or a fad. The technology is changing the lives...

My Top AI Healthcare Stock to Buy and Hold for 20 Years
Simply Wall St 21h
Eli Lilly Valuation Check After Breakthrough Therapy Status For Sofetabart Mipitecan

The FDA’s Breakthrough Therapy designation for Eli Lilly (LLY) candidate sofetabart mipitecan in platinum resistant ovarian cancer has pushed oncology back into...

Eli Lilly Valuation Check After Breakthrough Therapy Status For Sofetabart Mipitecan
The Motley Fool 2d
Should You Dump Eli Lilly's Shares After This Setback?

The company got some bad news to start 2026. Competition in the weight loss market is heating up. The two leaders, Eli Lilly (LLY 2.05%) and Novo Nordisk (NVO...

Should You Dump Eli Lilly's Shares After This Setback?
Simply Wall St 2d
Is It Too Late To Consider Eli Lilly After Its 36% One Year Surge?

If you have ever wondered whether Eli Lilly shares are priced for perfection or still offer room for value, this article is written with you in mind. The stock...

Is It Too Late To Consider Eli Lilly After Its 36% One Year Surge?
Simply Wall St 3d
Schrödinger Valuation Check As New AI Partnerships With Manas AI And Eli Lilly Take Shape

Advertisement AI partnerships put Schrödinger (SDGR) in focus Schrödinger (SDGR) has moved into the spotlight after a multi-year agreement with Manas AI for d...

Schrödinger Valuation Check As New AI Partnerships With Manas AI And Eli Lilly Take Shape
The Motley Fool 3d
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?

Eli Lilly's valuation has been driven higher by investor excitement around GLP-1 drugs, leaving other drugmakers languishing. Over short periods, Wall Street i...

Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?
TipRanks 3d
Lilly’s Orforglipron Moves Deeper Into Heart-Risk Testing: What Investors Should Know

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Study Overview This Phase 3 study from Eli Li...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.